Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Net Loss	$ (672,500)	$ (3,902,900)
Depreciation and amortization	121,300	66,700
Stock-based compensation expense	169,700	185,800
Change in fair value of derivative instruments – warrants	(1,133,700)	3,448,700
Accretion of warrants liability for consulting services	(49,800)	73,500
Revenue deferred to future periods	841,400	794,900
Recognition of deferred revenue	(1,098,600)	(1,075,800)
Changes in severance liability	(46,200)	(77,100)
Changes in deferred rent	4,900	(6,200)
Changes to allowance for doubtful accounts	(18,900)	(18,300)
Changes in operating assets and liabilities:
Accounts receivable	213,300	282,300
Prepaid expenses	(77,000)	16,800
Accounts payable and accrued expenses	(46,500)	91,100
Net Cash Used in Operating Activities	(1,792,600)	(120,500)
Cash Flows Used In Investing Activities:
Capital expenditures	(23,700)	(20,000)
Capitalized software development costs		(427,800)
Net Cash Used In Investing Activities	(23,700)	(447,800)
Cash Flows Provided By Financing Activities:
Proceeds from exercise of warrants	260,000	120,200
Proceeds from exercise of employee stock options	43,600	63,200
Proceeds from private placement of stock and warrants, net of issuance costs	3,370,000
Net Cash Provided By Financing Activities	3,673,600	183,400
Net Increase (Decrease) in Cash	1,857,300	(384,900)
Cash - Beginning of Period	2,430,700	3,960,600
Cash - End of Period	$ 4,288,000	$ 3,575,700